FDA Inspection 1310026 — Avantec Vascular Corporation
The FDA completed an inspection of Avantec Vascular Corporation on March 24, 2026 in Sunnyvale, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 24, 2026
- Fiscal Year
- 2026
- Product Type
- Devices
- Project Area
- Postmarket Assurance: Devices
- Location
- Sunnyvale, CA (United States)